endometrial hyperplasia with atypia,
estrogen-progestin therapy in the 2 months before enrollment,
autoimmune diseases,
chronic, metabolic, systemic and endocrine disorders, including hyperandrogenism, hyperprolactinemia, diabetes mellitus and thyroid disease,
hypogonadotropic hypogonadism,
majors clinical conditions
